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Background
Type I interferon (IFN) induces blocks to various steps
of viral life cycles. It has been known for a long time
that treatment of certain cell types with IFN confers a
potent block to both the early and late steps of HIV-1
replication. However, the early block has remained
poorly characterized so far.
Material and methods
We have investigated in detail the effect of type I IFN
on HIV-1 infection in cell types relevant to natural
infection, including primary CD4+ T cells, monocyte-
derived macrophages, as well as several monocytic and
T cell lines.
Results
We have found that IFN treatment of macrophages,
THP-1 cells, and to a lesser extent CD4+ T cells, has a
profound effect on the outcome of HIV-1 infection,
whereas the effect is much less pronounced in U937
cells and minimal in various T cell lines. We have also
shown that IFN exerts potent anti-viral effects against a
broad range of retroviruses, including diverse HIV-1
strains (IIIB, BK132, NL4-3, YU-2, Ba-L), HIV-1 derived
lentiviral vectors (LVs), SIVmac and FIV LVs, as well as
B-MLV. Using a BlaM-Vpr entry assay, we have
observed that viral entry is not affected by IFN treat-
ment. More specifically, the block directly correlates
with a strong decrease in the accumulation of viral
cDNAs.
As APOBEC3 proteins are IFN regulated, we have
asked whether they have the capacity to edit reverse
transcripts generated by incoming wild type HIV-1
viruses in macrophages. Using single genome sequen-
cing, we have shown that viral cDNAs from IFN treated
macrophages bear a low but statistically significant
amount of G-to-A mutations that are acquired post-
entry. Based on the sites that are subjected to editing,
we predict that APOBEC3 proteins beyond APOBEC3G
play a role in this process.
Conclusions
Taken together, our results indicate that one or several
effectors of the type I IFN response are able to block
viral DNA accumulation of distant retroviruses in pri-
mary macrophages and CD4+T cells. In addition, we
have shown that the classic hallmark of APOBEC3-
mediated editing is observed on viral cDNAs recovered
from IFN treated macrophages. Given the low muta-
tional frequency noted in these experiments, it seems
unlikely that the editing shown here is an essential effec-
tor of the potent IFN induced antiviral effect. Instead it
is more likely to provide an additional mechanism to
augment other sources of HIV-1 sequence
diversification.
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